Source:http://linkedlifedata.com/resource/pubmed/id/18250547
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2008-2-5
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0916-9636
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1011-3
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18250547-Adrenergic alpha-1 Receptor Antagonists,
pubmed-meshheading:18250547-Adrenergic alpha-Antagonists,
pubmed-meshheading:18250547-Blood Pressure,
pubmed-meshheading:18250547-Doxazosin,
pubmed-meshheading:18250547-Humans,
pubmed-meshheading:18250547-Hypertension,
pubmed-meshheading:18250547-Time Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
New insights into the therapeutic management of morning hypertension with alpha1-adrenergic receptor blockers.
|
pubmed:publicationType |
Editorial,
Comment
|